Our fresh
news !

On our Start-up Side

Huntxx Pharma parle d'Angels Santé

A la découverte de nos start-ups- HuntX Pharma (FR)

Rencontrez Tushendan Rasiah, CEO de CliniSciences Group. Depuis plus de 40 ans, CliniSciences Group commercialise des réactifs, des consommables et des instruments pour la recherche et le diagnostic dans toute l’Europe.

Angels Santé participe à la levée de fonds de 1,7M€ d’HuntX Pharma

HEPHAISTOS-Pharma, a biotechnology company developing new-generation immunotherapies targeting innate immunity to increase patient cure rates, has 4.5 million seed financing round, in which Angels Santé participated, to finance Angels Santé, to finance industrialization and advance its lead candidate ONCO- Boost into the clinic.

Angels Santé takes part in HEPHAISTOS-Pharma's €10.3M fund-raising round (FR)

HEPHAISTOS-Pharma, a biotechnology company developing new-generation immunotherapies targeting innate immunity to increase patient cure rates, has 4.5 million seed financing round, in which Angels Santé participated, to finance Angels Santé, to finance industrialization and advance its lead candidate ONCO- Boost into the clinic.

ABCELY raises over €2.4m to accelerate the development of its innovative anti-cancer therapeutic approach (FR)

Abcely, a Nantes-based biotech developing a brand-new anti-cancer treatment, announces that it has raised over €2.4 million from Angels Santé, Go Capital, ICO and several private investors.